top of page

Search Results

500 results found for "Dr. David Gloriam"

Posts (180)

  • GBCRdb for beginners

    Join us for a fantastic introduction to GPCRdb with Dr. David Gloriam and Dr. Albert Kooistra. Register today: https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

  • New Resources in GPCRdb

    Be sure to signup for the next Virtual Cafe of Dr. GPCR on the 24th of June! This time, the GPCRdb team ( Dr. David Gloriam , Dr. Reserve your spot for free at: https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #GPCR #GPCRs #DrGPCR

  • Dr. Adriano Marchese - Dr. GPCR Podcast

    Episode 56 of the Dr. GPCR podcast is now available! Our guest is Dr. Adriano Marchese! Listen where you get your podcasts https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #drgpcr #gpcr #podcast

View All

Other Pages (311)

  • Ep 33 with Dr. David E. Gloriam

    Ep 33 with Dr. David E. Gloriam Dr. GPCR Podcast << Back to podcast list Dr. David E. Gloriam !

  • Ep 118 with Dr. David Sykes

    Ep 118 with Dr. David Sykes Dr. GPCR Podcast << Back to podcast list Dr. David Sykes About Dr. David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD David has over 20+ years of experience working in a drug discovery environment mainly in a specialist In 2014 David joined the University of Nottingham and began a part-time PhD in Molecular Pharmacology David Sykes on the web Veprintsev Lab ResearchGate LinkedIn Dr.

  • Ep 143 with Dr Davide Calebiro

    Ep 143 with Dr Davide Calebiro Dr. GPCR Podcast << Back to podcast list Dr. Davide Calebiro About Dr. Davide Calebiro "Davide Calebiro is Chair of Molecular Endocrinology and Wellcome Trust Senior Research Davide’s work has been published in prestigious scientific journals such as Nature, Cell, New England Dr. Davide Calebiro on the web University of Birmingham Twitter Google Scholar LinkedIn Dr.

View All

Powered by


All Rights Reserved © 2020 - 2024

Dr. GPCR CORP is a 501(c)(3) non profit organization

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
bottom of page